Skip to main content

COVID-19 CISA (Clinical Immunization Safety Assessment) Clinical Consultation

Description
Healthcare providers and health departments in the U.S. can request a consultation for a complex COVID-19 vaccine safety question that is (1) about an individual patient residing in the U.S. or vaccine safety issue and (2) not readily addressed by CDC or Advisory Committee on Immunization Practices guidelines.
Date
12/2020
Type
Hotline
Organization
Centers for Disease Control and Prevention
Tagged as
Health workforce education and training · Infectious diseases · Vaccination